Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis

BACKGROUND: The prognostic value of EGFR and KRAS mutations in resected non-small cell lung cancer (NSCLC) has been reported. However, conflicting results were reported in these studies. The effect of mutations in these two genes in resected NSCLC remains controversial. METHODS: We searched Internet...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Manag Res
Auteurs principaux: Zhang, Shi-Ming, Zhu, Qing-Ge, Ding, Xiao-Xiao, Lin, Song, Zhao, Jing, Guan, Lei, Li, Ting, He, Bing, Zhang, Hu-Qin
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6138965/
https://ncbi.nlm.nih.gov/pubmed/30237741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S167578
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires